Bundamedik Tbk PT vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how Bundamedik Tbk PT (BMHS) and HCA Healthcare (HCA) compare, as of Aug 11, 2026.
As of Aug 11, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Bundamedik Tbk PT trades at IDR 191 versus a fair value of IDR 32 (-83%), while HCA Healthcare trades at $413 versus $555 (+34%).
Bundamedik Tbk PT
BMHS.JK · IDR · Health Care
-83%
upside to fair value
overvalued
PriceIDR 191
Fair ValueIDR 32
Quality46/100
HCA Healthcare
HCA · USD · Health Care
+34%
upside to fair value
undervalued
Price$413
Fair Value$555
Quality70/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Bundamedik Tbk PTHCA Healthcare
Valuation
169.2×P/E (TTM)12.5×
0.94×P/S (TTM)1.06×
0.78×P/B—
8.7×EV/EBITDA7.8×
—PEG1.18×
—Dividend yield0.8%
—Dividend per share$2.94
Profitability
1%Net margin9%
4%Operating margin15%
1%Return on equity136%
1%Return on assets12%
Growth
-2%Revenue growth (YoY)4%
-0.9%Avg. growth/yr (3Y)7.9%
7.1%Avg. growth/yr (5Y)8.0%
Balance & size
0.37×Debt / equity—
$151MMarket cap$81B
healthyGrowth qualityhealthy
HCA Healthcare leads: 1 to 9 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Bundamedik Tbk PTof which business quality 47 · market factors 47HCA Healthcareof which business quality 66 · market factors 46
ProfitabilityMargins and returns on capital today
21
76
Quality GrowthAre margins and returns improving?
33
61
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
49
75
Low VolatilityCalm price path (market factor)
70
59
MomentumPrice trend over the last 3–12 months (market factor)
36
38
52W MomentumDistance to the 52-week high (market factor)
40
44
Net IssuanceBuybacks instead of dilution
100
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Bundamedik Tbk PT
DCF ModelsIDR 138
Earnings-BasedIDR 17
MultiplesIDR 109
Asset-BasedIDR 152
Growth DCFIDR 122
Economic ProfitIDR 146
Growth EarningsIDR 27
19 of 23 models see the stock below the current price.
HCA Healthcare
DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506
6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Bundamedik Tbk PT
Bear IDR 24Fair Value IDR 32Bull IDR 40
IDR 191 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$413 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Bundamedik Tbk PT · Health Care
Quality score46 · below median
Fair value upside-83% · bottom 25%
HCA Healthcare · Health Care
Quality score70 · Top 25%
Fair value upside+34% · Top 25%
Bottom line
As of Aug 11, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Bundamedik Tbk PT trades at IDR 191 versus a fair value of IDR 32 (-83%), while HCA Healthcare trades at $413 versus $555 (+34%).
HCA Healthcare has the higher quality score (70/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
